Insiders Teva Pharmaceutical Industries Limited

Equities

TEVA

US8816242098

Market Closed - Nyse Other stock markets 01:30:03 22/06/2024 am IST			5-day change	1st Jan Change
16.96 ^USD	-0.59%		-1.17%	+62.45%

20/06	Teva Pharmaceutical Industries 'Well-Positioned' for Further Growth, UBS Says	MT
14/06	Global markets live: Tesco, Adobe, Tyson Foods, GameStop, Teva...

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Teva Pharmaceutical Industries Insider Sold Shares Worth $470,794, According to a Recent SEC Filing	17/05	MT
Teva Pharmaceutical Industries Insider Sold Shares Worth $254,807, According to a Recent SEC Filing	15/05	MT
Teva Pharmaceutical Industries Limited Announces Management Changes, Effective June 3, 2024	15/05	CI
Teva Pharmaceutical Industries Insider Sold Shares Worth $657,240, According to a Recent SEC Filing	08/03	MT
Teva Pharmaceutical Industries Insider Sold Shares Worth $1,048,119, According to a Recent SEC Filing	08/03	MT
Teva Pharmaceutical Industries Insider Sold Shares Worth $1,352,090, According to a Recent SEC Filing	08/03	MT
Teva Pharmaceutical Industries Insider Sold Shares Worth $414,270, According to a Recent SEC Filing	06/03	MT
Teva Pharmaceutical Industries Insider Sold Shares Worth $1,277,207, According to a Recent SEC Filing	06/03	MT
Teva Pharmaceutical Industries Insider Sold Shares Worth $270,176, According to a Recent SEC Filing	01/03	MT
Teva Pharmaceutical Industries Ltd. Appoints R. Ananthanarayanan as CEO of Its Teva Active Pharmaceutical Ingredients Business	08/11	CI
Teva Announces Changes to Executive Management Team	29/23/29	CI
Insider Sell: Teva Pharmaceutical Industries	10/23/10	MT
Insider Sell: Teva Pharmaceutical Industries	03/23/03	MT
Teva Pharmaceutical Industries Limited Appoints Varda Shalev as Member of the Board, Effective September 1, 2023	03/23/03	CI
INTERVIEW - Richard Francis, CEO of Teva Pharmaceutical: solid quarter, full-year forecasts raised	03/23/03	MT
Teva Announces Appointment of Dr. Angus Grant to Executive Vice President, Business Development, Effective August 1, 2023	27/23/27	CI
Jean-Michel Halfon to Resign from Board of Directors of Teva Pharmaceutical Industries Limited	12/23/12	CI
Insider Sell: Teva Pharmaceutical Industries	09/23/09	MT
Insider Sell: Teva Pharmaceutical Industries	09/23/09	MT
Insider Sell: Teva Pharmaceutical Industries	09/23/09	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Teva Pharmaceutical Industries isn't out of the woods yet

February 01, 2024 at 03:11 pm IST

INTERVIEW - Richard Francis, CEO of Teva Pharmaceutical: solid quarter, full-year forecasts raised

August 03, 2023 at 12:49 am IST